文献速递腹部MR

肝脏MRI质子密度脂肪分数与肝病风险之间的关联

Association between Liver MRI Proton Density Fat Fraction and Liver Disease Risk.
PubMed 文献 · Radiology · 2023-01-01

该研究基于英国生物银行和FinnGen的汇总数据及英国生物银行个体数据,采用孟德尔随机化分析遗传预测的肝脏MRI质子密度脂肪分数(PDFF)与肝病风险的因果关系,并用多变量孟德尔随机化探讨中介因素。结果显示遗传预测的高PDFF与多种肝病风险升高相关,个体水平逻辑回归验证了这些关联,部分关联由高密度脂蛋白胆固醇、2型糖尿病和腰臀比介导。

要点

  • 遗传预测的高肝脏MRI PDFF与多种肝病风险升高相关,包括非酒精性脂肪性肝病、非酒精性脂肪性肝炎、肝纤维化、肝硬化及恶性肝肿瘤。
  • 在个体水平数据中,基于PDFF多基因风险评分分组后仍支持上述关联(所有P < .004)。
  • 中介分析显示,高密度脂蛋白胆固醇、2型糖尿病和腰臀比可能介导PDFF与部分肝病(肝纤维化和肝硬化、肝硬化、NAFLD)的关联。

核心结论

  • 本研究提供了遗传预测的肝脏MRI PDFF与肝脏健康之间存在关联的证据。

研究设计与样本

  • 基于人群的前瞻性观察性研究,使用主要来自英国生物银行和FinnGen的汇总数据(32858名参与者)及英国生物银行个体数据(378436名参与者,平均年龄57岁±8[SD],其中203108名女性),采用逆方差加权孟德尔随机化分析,并以Bonferroni校正,个体数据下载于2020年8月至12月,用逻辑回归验证PDFF多基因风险评分与肝病风险的关联,并用多变量孟德尔随机化进行中介分析。

诊断标准与关键数值

  • 遗传预测的高肝脏MRI PDFF与恶性肝肿瘤风险升高相关(OR 4.5,P < .001)。
  • 遗传预测的高肝脏MRI PDFF与酒精性肝病风险升高相关(OR 1.9,P < .001)。
  • 遗传预测的高肝脏MRI PDFF与肝纤维化和肝硬化风险升高相关(OR 3.0,P < .004)。
  • 遗传预测的高肝脏MRI PDFF与肝纤维化风险升高相关(OR 3.6,P = .002),与肝硬化风险升高相关(OR 3.8,P < .001)。
  • 遗传预测的高肝脏MRI PDFF与非酒精性脂肪性肝炎风险升高相关(OR 7.7,P < .001),与非酒精性脂肪性肝病风险升高相关(OR 4.4,P < .001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background A better understanding of the association between liver MRI proton density fat fraction (PDFF) and liver diseases might support the clinical implementation of MRI PDFF. Purpose To quantify the genetically predicted causal effect of liver MRI PDFF on liver disease risk. Materials and Methods This population-based prospective observational study used summary-level data mainly from the UK Biobank and FinnGen. Mendelian randomization analysis was conducted using the inverse variance-weighted method to explore the causal association between genetically predicted liver MRI PDFF and liver disease risk with Bonferroni correction. The individual-level data were downloaded between August and December 2020 from the UK Biobank. Logistic regression analysis was performed to validate the association between liver MRI PDFF polygenic risk score and liver disease risk. Mediation analyses were performed using multivariable mendelian randomization. Results Summary-level and individual-level data were obtained from 32 858 participants and 378 436 participants (mean age, 57 years ± 8 [SD]; 203 108 female participants), respectively. Genetically predicted high liver MRI PDFF was associated with increased risks of malignant liver neoplasm (odds ratio [OR], 4.5; P < .001), alcoholic liver disease (OR, 1.9; P < .001), fibrosis and cirrhosis of the liver (OR, 3.0; P < .004), fibrosis of the liver (OR, 3.6; P = .002), cirrhosis of the liver (OR, 3.8; P < .001), nonalcoholic steatohepatitis (OR, 7.7; P < .001), and nonalcoholic fatty liver disease (NAFLD) (OR, 4.4; P < .001). Individual-level evidence supported these associations after grouping participants based on liver MRI PDFF polygenic risk score (all P < .004). The mediation analysis indicated that genetically predicted high-density lipoprotein cholesterol, type 2 diabetes mellitus, and waist-to-hip ratio (mediation effects, 25.1%-46.3%) were related to the occurrence of fibrosis and cirrhosis of the liver, cirrhosis of the liver, and NAFLD at liver MRI PDFF (all P < .05). Conclusion This study provided evidence of the association between genetically predicted liver MRI PDFF and liver health. © RSNA, 2023 Supplemental material is available for this article. See also the editorials by Reeder and Starekova and Monsell in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Xia T, Du M, Li H, et al. Association between Liver MRI Proton Density Fat Fraction and Liver Disease Risk. Radiology. 2023. PMID: 37874242. doi:10.1148/radiol.231007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。